Lee F D
Department of Pathology, Glasgow Royal Infirmary.
J Clin Pathol. 1993 Feb;46(2):118-22. doi: 10.1136/jcp.46.2.118.
To investigate the possibility that the incidence of apoptotic bodies in the cryptal epithelium might help to identify colonic lesions due to drugs, especially non-steroidal anti-inflammatory drugs (NSAIDs).
The apoptotic count (AC) the number of apoptotic bodies per 100 crypts was calculated in a series of colorectal biopsy specimens, stained with haematoxylin and eosin from patients with (a) known or suspected drug induced colitis and (b) inflammatory bowel disease before or after treatment with salazopyrine or corticosteroids. These specimens were compared with normal biopsy specimens from a control group of comparable age and sex distribution.
Under normal conditions apoptotic bodies were seldom seen at all and the mean apoptotic count was less than 1.0. In untreated inflammatory bowel disease the mean apoptotic count was marginally increased (2.4), but when there was a partial response to drug treatment the apoptotic count rose to 13.1 (p 0.003). In colonic lesions directly attributable to drugs the apoptotic count was always increased, reaching its highest level (106) with 5-fluorouracil. In colitis related to NSAIDs apoptoses were associated with inflammation, most notably an increase in lymphocytes in both lamina propria and epithelium.
The presence of crypt apoptoses in substantial numbers (with an apoptotic count in excess of 5) should always raise the possibility of drug effect. The mechanisms involved are not clear but with NSAIDs the changes might well be immunologically mediated.
研究隐窝上皮细胞中凋亡小体的发生率是否有助于识别药物引起的结肠病变,尤其是非甾体抗炎药(NSAIDs)所致病变。
计算一系列结直肠活检标本中的凋亡计数(AC),即每100个隐窝中凋亡小体的数量。这些标本用苏木精和伊红染色,取自以下患者:(a)已知或疑似药物性结肠炎患者;(b)在用柳氮磺胺吡啶或皮质类固醇治疗之前或之后的炎症性肠病患者。将这些标本与年龄和性别分布相当的对照组的正常活检标本进行比较。
在正常情况下,很少能见到凋亡小体,平均凋亡计数小于1.0。在未经治疗的炎症性肠病中,平均凋亡计数略有增加(2.4),但当对药物治疗有部分反应时,凋亡计数升至13.1(p<0.003)。在直接由药物引起的结肠病变中,凋亡计数总是增加的,5-氟尿嘧啶导致的凋亡计数达到最高水平(106)。在与NSAIDs相关的结肠炎中,凋亡与炎症相关,最明显的是固有层和上皮中的淋巴细胞均增多。
大量隐窝凋亡(凋亡计数超过5)的存在应始终提示药物作用的可能性。其涉及的机制尚不清楚,但对于NSAIDs而言,这些变化很可能是由免疫介导的。